Arcus Biosciences, Inc. · NYSE:RCUS

Gilead Sciences, Inc. reported a 29.70% stake in Arcus Biosciences, Inc. (Schedule 13D/A)

Event Jul 13, 2025 · Filed Jul 15, 2025

Gilead Sciences, Inc. reported a 29.70% stake in Arcus Biosciences, Inc., 31,424,760 shares, with active intent on Jul 13, 2025. Filed Jul 15, 2025 (Schedule 13D/A).

Stake
29.70%
Shares
31,424,760
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
GILEAD SCIENCES, INC.29.70%31,424,760

Source

View original at SEC

Related